Thermo Fisher Scientific Inc (TMO) (Q3 2026) Earnings Call Highlights: Revenue Up 9% to $12.14 Billion, Adjusted EPS Jumps 15% and Full-Year Guidance Raised

gurufocus.com · 2026-10-21

Revenue: Q3 revenue grew 9% to $12.14 billion; organic growth 6%, acquisitions contributed 4%, microbiology divestiture reduced 1%.Adjusted Operating Income: Gr

TickrTrends take: Thermo Fisher's third quarter results showed revenue growth of 9 percent alongside adjusted earnings per share growth of 15 percent, demonstrating operational leverage that outpaced top-line expansion. The company's decision to raise full-year guidance suggests management confidence in sustained momentum through the close of fiscal 2026. Given TickrTrends' assessment that TMO is fairly valued, investors should monitor whether this earnings beat and raised outlook narrow or widen any valuation gap relative to historical multiples in the Healthcare sector.

Read the full story at gurufocus.com →